CorMedix (CRMD) Free Cash Flow (2016 - 2025)
CorMedix has reported Free Cash Flow over the past 15 years, most recently at $92.7 million for Q4 2025.
- Quarterly results put Free Cash Flow at $92.7 million for Q4 2025, up 1748.72% from a year ago — trailing twelve months through Dec 2025 was $172.8 million (up 440.59% YoY), and the annual figure for FY2025 was $172.8 million, up 440.59%.
- Free Cash Flow reached $92.7 million in Q4 2025 per CRMD's latest filing, up from $30.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $92.7 million in Q4 2025 and bottomed at -$17.4 million in Q1 2024.
- Median Free Cash Flow over the past 5 years was -$6.4 million (2021), compared with a mean of $1.8 million.
- The largest annual shift saw Free Cash Flow crashed 308.37% in 2021 before it skyrocketed 1748.72% in 2025.
- Over 5 years, Free Cash Flow stood at -$6.5 million in 2021, then grew by 3.3% to -$6.3 million in 2022, then tumbled by 75.72% to -$11.0 million in 2023, then skyrocketed by 49.06% to -$5.6 million in 2024, then surged by 1748.72% to $92.7 million in 2025.
- Business Quant data shows Free Cash Flow for CRMD at $92.7 million in Q4 2025, $30.4 million in Q3 2025, and $30.0 million in Q2 2025.